Guardant Health

GH · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reports earnings in about 1 month

Previous year: -$0.62

-19.4%

Oncology Test Volume

79K

Shield Screening Test Volume

38K

Previous year: 6.4K

+493.8%

Non-GAAP Gross Margin

Previous year: -$83.4M

-35.0%

Total Assets

$2.01B

Previous year: $1.49B

+35.5%

Loading...

Guardant Health

Unlock previous datapoints

Upgrade

Guardant Health

Unlock previous datapoints

Upgrade

Guardant Health Revenue by Segment

Revenue by Segment

Oncology Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Biopharma & Data Revenue

CapyFin.com

Screening Revenue

CapyFin.com

Licensing and Other Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$11B

P/E Ratio

-48.41

Sector

N/A

Industry

N/A

52-Week High

$117

52-Week Low

$37

Oncology Test Volume

79K

Shield Screening Test Volume

38K

Non-GAAP Gross Margin

66%

GAAP Gross Margin

65%

Products

Get in Touch

Resources

Guardant Health

Guardant Health

Guardant Health

Guardant Health Revenue by Segment

Revenue by Segment

Oncology Revenue

Biopharma & Data Revenue

Screening Revenue

Licensing and Other Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics